Deals
Glaxo Has No Plans to Spin Off Consumer Health-Care Division
This article is for subscribers only.
GlaxoSmithKline Plc, the U.K.’s biggest drug maker, has no plans to spin off its consumer health-care division, a spokesman said today.
While the company won’t rule out the possibility of one day shedding the unit, it’s not currently being considered, said Simon Steel. The Financial Times reported the possibility of a spinoff yesterday.